Delivery Order SPE2DB20D3101-SPE2DB22FJ9Q4
- Not listed
- This federal contract award is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The award has a ceiling value of $19,139.80 and a period of performance through September 28, 2023. This is a delivery order contract with a firm fixed price pricing type. The contract is not...
- This federal contract award is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 240ML to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor. The contract has a ceiling value of $6,480.40 and is a Delivery Order with a Firm Fixed Price pricing type. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- This federal contract award is for the supply of NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 10, 2024 as a delivery order with a ceiling value of $7,232.91. The contract has a firm fixed price pricing type and an ultimate completion date of December 11, 2024. There is no set-aside designation for this...
- This federal contract award is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 19, 2021, with a ceiling value of $8,495.18. The contract is a Delivery Order with a Firm Fixed Price pricing type and a completion date of November 22, 2021. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit...
- This contract award is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $11,127.24, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a...
- This federal contract award is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,287.37 and was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of December 4, 2024. The contract is not designated as a set-aside....
- The federal contract award is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $11,124.66. This is a delivery order contract with a firm fixed price, and the ultimate completion date is July 29, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp's Corporate Office division...
- This federal contract award is for the delivery of Nitrofurantoin 25 mg/5 ml suspension, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor. The contract, valued at $24,662.14, is a delivery order with a firm fixed price. It does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $16,243.75, is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product. The contract has an ultimate completion date of May 16, 2023 and is a Firm Fixed Price Delivery Order. The contract is not set-aside and was awarded through full and open competition. Amerisourcebergen Drug Corp is a major...
- This federal contract award is for the delivery of NITROFURANTOIN MCR 25 MG CAP 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $8,345.87 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of July 12, 2024. The contract is not designated as a set-aside....
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB22FJ9Q4Delivery Order
This federal contract award is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price of $23,916.73 and an Ultimate Completion Date of May 31, 2022. It was awarded on May 27, 2022. There is no set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, running through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.9k | 5/27/22 |